Recital 39, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

The Commission’s investigation revealed that while this second group of

customers can technically use either non-GM or GM produced lactase, there are indications that non-GM places a limited competitive constraint on GM. product, is essentially the same for GM and non-GM lactases” (Form CO, para. 678). Consequently, the Commission has no reason to believe respondents would modify their answers if they were asked instead about the time and investment needed for a company already active in the manufacture of food and beverage enzymes to start producing and commercially supplying non-GM produced lactase. 49 eRFI to competitors and distributors, question B.7. 50 eRFI to customers, question B.7. 51 eRFI to competitors and distributors, question B.8. 52 This is in line with the Parties’ views and Article 11 of Regulation (EU) 2018/848 which states that "GMOs, products produced from GMOs, and products produced by GMOs shall not be used in food, feed, processing aids […] in organic production". 53 To estimate the share of the market those customers represent, the Parties explain that less than 10% of the lactase sold globally and in the EEA goes into organic production (Form CO. para. 673 and 674). Another manufacturer estimates that customers bound to use non-GM produced lactase represent 25% of the market (Minutes of a call with a manufacturer, 10 October 2023, para. 12).